Utilize AI to analyze application runtime data (e.g., rendering time, communication latency), obtain optimization suggestions (such as reducing component re-rendering, reusing hardware connections), ...
Background: Systematic literature reviews (SLRs) are critical to health research and decision-making but are often time- and labor-intensive. Artificial intelligence (AI) tools like large language ...
Simultaneous publication in Journal of the American College of Cardiology demonstrates impact of ECG-AI on heart failure risk assessment CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in AI-powered cardiovascular diagnostics, today announced new groundbreaking clinical data presented at the American Heart Association (AHA) ...
Simultaneous publication in Journal of the American College of Cardiology demonstrates impact of ECG-AI on heart failure risk assessment Anumana, a leader in AI-powered cardiovascular diagnostics, ...
Marcus Patel felt a mixture of pride and unease as he stood at the head of the conference table, waiting for his leadership team to gather. Two years ago he’d been recruited from Silicon Valley to ...
Every day, millions of people input prompts (whether questions or instructions) into AI tools such as ChatGPT, Perplexity, Claude, DALL-E, or Meta AI. Recently, media coverage highlighted what seemed ...
Figure 1. Exercise/rest measurements of the standardized uptake value ratio (SUVR) are used with an exponential calibration function to estimate myocardial flow reserve (MFR). This allows (i) the ...
The ocean drives economic prosperity and environmental stability for billions of people. Yet it is under threat from overfishing, pollution and climate change. Public financing isn’t enough to respond ...
Abstract: The aim of this study is to present a good example of the triple helix model operation through the results of a hackathon from Szekesfehervar. The examined “Junior Engineers Camp – Harman ...
Affimed N.V., a clinical-stage immuno-oncology company, announced that an abstract on its phase 2 LuminICE-203 study involving the innate cell engager acimtamig in combination with AlloNK has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback